News & Updates
Filter by Specialty:

Guselkumab safe, well tolerated in patients with psoriatic arthritis
Treatment with the monoclonal antibody targeting interleukin [IL]-23p19 guselkumab 100 mg, given either every 4 (Q4W) or 8 weeks (Q8W), is well tolerated in patients with psoriatic arthritis (PsA), with no new safety concerns through 1 year, according to pooled results of the DISCOVER-1 and DISCOVER-2 phase III trials.
Guselkumab safe, well tolerated in patients with psoriatic arthritis
10 Dec 2021
Alcohol abstinence lowers HCC risk in patients with cirrhosis
Abstinence from alcoholic drinks reduces the risk of hepatocellular carcinoma (HCC) in patients with alcohol-related liver cirrhosis, but not in those with a history of decompensated disease, reveals a study.
Alcohol abstinence lowers HCC risk in patients with cirrhosis
10 Dec 2021
High meat intake ups risk of lung cancer
A diet with increased consumption of fruits, vegetables, breakfast cereals, and dietary fibre, as well as low intake of red and processed meat, appears to reduce the risk of lung cancer, suggests a study.
High meat intake ups risk of lung cancer
10 Dec 2021
Wearables capture patterns of activity, gait, tremors in Parkinson’s disease patients
Parkinson’s disease (PD) significantly impairs activity even when patients are in their natural environment, according to a recent real-world study.